Michael E. Minshall, MPH

home / authors / michael-e-minshall-mph

Articles

November 6th 2009

A Payer's Perspective on the Cost Effectiveness of Gastric Bypass Surgery

Afschin Gandjour, MD, PhD. Reply by Sayeed Ujranyddubm MD Therese Swan C. David Kingman, PhF Michael E. Minshall, MPH

September 7th 2009

Cost-Effectiveness of Roux-en-Y Gastric Bypass in Type 2 Diabetes Patients

Sayeed Ikramuddin, MD C. David Klingman, PhD Therese Swan, BA Michael E. Minshall, MPH

A predictive health economic model indicated that Roux-en-Y gastric bypass is cost-effective in the treatment of type 2 diabetes mellitus compared with medical management.

June 7th 2008

Cost-Effectiveness of Blood Glucose Monitoring Is Controversial

Sherrie L. Aspinall, PharmD, MSc Peter A. Glassman, MBBS, MSc. Author reply by Sandra L. Tunis, PhD Michael E. Minshall, MPH

June 7th 2008

The Importance of Recognizing Patients' Time as a Cost of Self-Management

Louise B. Russell, PhD Monika M. Safford, MD. Author reply by Sandra L. Tunis, PhD Michael E. Minshall, MPH

March 1st 2008

Self-monitoring of Blood Glucose in Type 2 Diabetes: Cost-effectiveness in the United States

Sandra L. Tunis, PhD Michael E. Minshall, MPH

For patients with type 2 diabetes taking oral antidiabetics, self-monitoring of blood glucose cost-effectiveness (1 and 3 times per day) was modeled. Both strategies represented good value in the US payer setting.

November 1st 1998

Review of the Pharmacoeconomic Research on Gemcitabine in the Treatment of Advanced Non-Small Cell Lung Cancer

Michael E. Minshall, MPH Astra M. Liepa, PharmD